The American Journal of Managed Care

First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of schizophrenia in adults. The FDA approved xanomeline and trospium chloride (Cobenfy) ...
Healio

FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more

Please provide your email address to receive an email when new articles are posted on . Recent FDA actions include approval of the first new treatment for acute stroke in 30 years. FDA also cleared a ...
Healio

FDA approves Ionis’ Tryngolza as first treatment for familial chylomicronemia syndrome

Please provide your email address to receive an email when new articles are posted on . The FDA approved Tryngolza for the treatment of adults with familial chylomicronemia syndrome when used in ...

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

Ianalumab+standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia

Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...
The American Journal of Managed Care

FDA Approves First Treatment for KRAS-Mutated Recurrent LGSOC

The combination of avutometinib and defactinib is the first FDA-approved treatment for KRAS-mutated recurrent LGSOC. Approval was based on the phase 2 RAMP-201 trial, showing a 44% overall response ...
Cure Today

‘No One-Size-Fits-All’ First-Line Treatment for Mantle Cell Lymphoma

Patients can now prioritize whether durable responses to treatment or avoiding certain side effects are more valuable to them. Progress in treating mantle cell lymphoma (MCL) has allowed patients to ...
mskcc.org

FDA Approves First Treatment for Patients With All Forms of Histiocytosis

Robin Bankins says the first time she spoke with MSK’s Dr. Eli Diamond about treating her histiocytosis, she trusted him right away. Based a clinical trial conducted at MSK, the FDA has approved the ...
WebMD

Ankylosing Spondylitis: When Your Treatment Isn’t Working

Ankylosing spondylitis (AS) is a condition that has a big impact on your spine. It literally means stiffening of the spine. You may have pain associated with the stiffness, often in your sacro-iliac ...
USA Today

FDA approves first treatment that delays Type 1 diabetes. Why it could be 'game changing'

This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment. Experts say the new ...
The New England Journal of Medicine

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

Immune thrombocytopenia is a rare autoimmune disorder with associated bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia is high-dose glucocorticoids, but side ...